ask="40.00"
ask_size="700"
average_daily_volume="494081"
bid="N/A"
bid_size="N/A"
book_value="6.19"
change="-0.79"
change_from_200_day_moving_average="1.44"
change_from_50_day_moving_average="-0.26"
change_from_52_week_high="-7.73"
change_From_52_week_low="17.60"
change_in_percent="-2.47%"
close="31.19"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-3.81"
eps_estimate_next_quarter="-1.03"
eps_estimate_next_year="-3.92"
ex_dividend_date="N/A"
float_shares="31803000"
high="32.05"
high_52_weeks="38.92"
last_trade_date="1/19/2017"
last_trade_price="31.19"
last_trade_size="7734"
last_trade_time="4:00pm"
low="31.07"
low_52_weeks="13.59"
market_capitalization="1.62B"
moving_average_200_day="29.75"
moving_average_50_day="31.45"
name="Theravance Biopharma
Inc. - Or"
notes="N/A"
one_year_target_price="34.71"
open="32.03"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+4.85%"
percent_change_from_50_day_moving_average="-0.83%"
percent_change_from_52_week_high="-19.86%"
percent_change_from_52_week_low="+129.51%"
previous_close="31.98"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.16"
price_per_sales="35.46"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="16.78"
stock_exchange="NGM"
symbol="TBPH"
volume="121298"
weeks_range_52="13.59 - 38.92"
